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Unresponsive acute otitis media is characterized by clinical signs and symptoms associated with otoscopic findings of 
inflammation that continue beyond 48 h of therapy. This occurs in about 10% of children treated initially with a 10-day 
course of antibiotics. This article reviews the management of this condition. 
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Unresponsive acute otitis media (AOM) is charac- 
terized by clinical signs and symptoms associated with 
otoscopic findings of inflammation which continue 
beyond 48 h of therapy. This occurs in about 10% 
of children treated initially with a 10-day course of 
antibiotics. Children should be seen for a reassessment 
when symptoms of AOM continue beyond 48 h or 
recur prior to the next scheduled visit. Hathaway et al. 
[I] reported that parental judgment of resolution 
and observation of symptoms can accurately identifj 
children with resolved AOM. Several studies have 
identified risk factors for unresponsive acute otitis 
media [I-41. Risk factors which have been identified 
for unresponsive AOM include age less than 12-15 
months, a prior history of recurrent otitis media in the 
child or a sibling, a history of antibiotic treatment of 
otitis media within the previous month, non-white 
males, concomitant viral infection and otitis during the 
winter respiratory season. 
MANAGEMENT 
Because of the difficulty in determining the reason that 
a child fails to respond to antibiotic treatment of acute 
otitis media, optimal management of these children 
is often unclear. Unresponsive AOM occurs more 
frequently when antibiotic therapy fails to eradicate 
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pathogens than when pathogens are eradicated. How- 
ever, organisms resistant to initial therapy can be 
identified in only about 19% of post-therapy aspirates 
[5]. Eradication of a sensitive middle ear pathogen with 
antibiotic therapy is less likely after 2-4 days when a 
virus and bacteria are both isolated from a middle ear 
aspirate than when bacteria are isolated alone [6].  
Persistent symptoms and otoscopic findings of inflam- 
mation are also associated with higher viral isolation 
rates from middle ear aspirates [7]. Pate1 et al. [ 8 ]  
reported the treatment outcomes of 99 children treated 
with amoxicillin clavulanate and followed with a 3-6- 
day post-treatment tympanocentesis. Eradication of the 
pathogen was achieved in 100% of 39 children who had 
Streptococcus pneumoniae isolated, 92% of 25 children 
with Moraxella catarrhalis, and 62% of 29 children with 
non-typeable Haemophilus injuenzae. However, only 
one of the cases in which the pathogen was not 
eradicated had an isolate which appeared resistant by 
MIC. Concomitant viral isolation from the middle ear 
fluid or nasal wash was associated with unresponsive- 
ness. Pichichero et al. [9] reported the results of 
tympanocenteses in 137 children seen in a Rochester, 
New York, private practice with unresponsive acute 
otitis media. Among 200 middle ear aspirates in the 137 
children, S. pneumoniae was isolated in 33 (24%) cases, 
H .  injtrenzae in 10 (7%), M .  catarrhalis in 9 (7%), 
S. pyogenes in 8 (6%), and Staphylococcus aureus in 7 
(5%), and no pathogen was isolated in 67 (49%). Two 
pathogens were isolated in three children (3%). 
Compared to untreated children presenting with acute 
otitis media, there was a trend to more isolations 
of B-lactamase organisms (83%) versus 44% for H .  
inztrenzne) and resistant S. pneumoniae (18% versus 8%). 
However, the differences did not reach statistical 
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significance. Antibiotic treatment based on in vitro 
sensitivity results from middle ear isolates failed to 
achieve a cure in 28% of cases [lo]. 
Based on the current data, I recommend treating 
unresponsive AOM in a child who has been treated 
initially with amoxicillin with trimethoprim plus 
sulfamethoxazole or erythromycin plus sulfisoxazole, 
and vice versa. The sequential administration of these 
antibiotics usually provides excellent coverage for most 
middle ear pathogens. Trimethoprim plus sulfa- 
methoxazole and erythromycin plus sulfamethoxazole 
cover most P-lactamase-producing organisms resistant 
to amoxicillin such as H .  injuenzae, M .  catarrhah, 
and many strains of Staphylococcus aureus, while 
amoxicillin covers organisms resistant to trimethoprim 
plus sulfamethoxazole such as S. pyogenes, group B 
streptococci, and enterococci. In areas where H. 
itguenzae is often resistant to trimethoprim plus 
sulfamethoxazole, consider administering amoxicillin 
plus clavulanate, azithromycin or clarithromycin. Un- 
fortunately, third-generation cephalosporins and 
amoxicillin plus clavulanate offer minimal advantage in 
covering highly resistant pneumococcal organisms. 
These more expensive antibiotics are mainly useful as 
second-line therapy for children who are allergic to 
antibiotics. If the child is allergic to amoxicillin but not 
cephalosporins, use a third-generation cephalosporin, 
azithromycin or clarithromycin to treat acute otitis 
media which has not responded to erythromycin plus 
sulfisoxazole or trimethoprim plus sulfisoxazole. If the 
child is allergic to an antibiotic containing sulfa, use 
amoxicillin plus clavulanate, a third-generation cephalo- 
sporin, azithromycin or clarithromycin when the otitis 
has not responded to amoxicillin. If unresponsive acute 
otitis media still persists after a second course of 
antibiotics, consider a myringotomy or tympano- 
centesis in order to isolate the pathogen and drain the 
effusion. 
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